21 November 2022
A Multidimensional Approach in the Management of Axial Spondylarthritis
There has been much focus on the pharmacologic management of axSpA. Despite optimal control of inflammation, symptoms of fatigue and pain can persist. Long term use of analgesics including opioids carries significant risks. Strategies to improve response to treatment in this population is critical.

A Year in Review Dr. Jack Cush reports on highlights from this annual session - featuring Drs. Carol Langford and John

Social Author Image
https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3.jpg
Tweet Author
RheumNow
Social Author Name
Dr. John Cush
Tweet Content
A Year in Review Dr. Jack Cush reports on highlights from this annual session - featuring Drs. Carol Langford and John Varga as discussants. #ACR22 https://t.co/RcBKzt50ky https://t.co/nyDHX9vqzz
Links
https://bit.ly/3XjQtWo

Differences in Presentation and Outcomes of Early vs Late Onset PsA Dr. Petryna ( @DrPetryna) discusses abstract 0377

Social Author Image
https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3.jpg
Tweet Author
RheumNow
Social Author Name
Dr. John Cush
Tweet Content
Differences in Presentation and Outcomes of Early vs Late Onset PsA Dr. Petryna ( @DrPetryna) discusses abstract 0377 presented at #ACR22. Abstract 0377: Differences in Early-onset vs. Late-onset PsA: Data from the RESPONDIA and REGISPONSER Studies https://t.co/Bw3RHp3lSR https://t.co/Yva84Iw8hk
Links
https://bit.ly/3i31QBN

What's Happening on the Hill? Dr. Rachel Tate ( @uptoTate) talks with Dr. Angus Worthing about #ACR22 Convergence Ses

Social Author Image
https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3.jpg
Tweet Author
RheumNow
Social Author Name
Dr. John Cush
Tweet Content
What's Happening on the Hill? Dr. Rachel Tate ( @uptoTate) talks with Dr. Angus Worthing about #ACR22 Convergence Session # 12S119 about legislative updates. https://t.co/zd6SVtSqrc https://t.co/7Y8ylkTSbx
Links
https://bit.ly/3EP0y6m

Rheumatology Roundup ACR22

21 November 2022
Rheumatology Roundup: ACR22

On Thursday, November 21, 2022, Dr. Arthur Kavanaugh and Dr. Jack Cush reviewed the best and most interesting data and sessions presented at ACR22 in Philadelphia, PA. These are the research abstracts discussed:

RA Topic Panel RheumNow recaps the best & most interesting data presented at #ACR22 in RA. Panelists: Drs.Conway, N

Social Author Image
https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3.jpg
Tweet Author
RheumNow
Social Author Name
Dr. John Cush
Tweet Content
RA Topic Panel RheumNow recaps the best & most interesting data presented at #ACR22 in RA. Panelists: Drs.Conway, Najm, Liew, Pope, Segan Follow: @RichardPAConway @AurelieRheumo @drdavidliew @Janetbirdope @JulianSegan https://t.co/6SAlQwcPS0 https://t.co/kSZgTQs6Ns
Links
https://bit.ly/3EPFOLV

Proposed Cancer Screening for Inflammatory Myositis Patients 11/12's plenary session features a novel proposal on how

Social Author Image
https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3.jpg
Tweet Author
RheumNow
Social Author Name
Dr. John Cush
Tweet Content
Proposed Cancer Screening for Inflammatory Myositis Patients 11/12's plenary session features a novel proposal on how and which patients with Idiopathic Inflammatory Myopathy (IIM) should be screened for cancer. https://t.co/uMhJu6eQt1 https://t.co/JeeeGadP4d
Links
https://bit.ly/3EPy6kZ
Subscribe to
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×